Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Express Scripts Holding Co    ESRX

EXPRESS SCRIPTS HOLDING CO (ESRX)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/18/2018 06/19/2018 06/20/2018 06/21/2018 06/22/2018 Date
80.48(c) 80.58(c) 80.1(c) 79.36(c) 79.23(c) Last
2 896 308 3 273 443 2 185 813 3 304 614 3 854 478 Volume
-1.55% +0.12% -0.60% -0.92% -0.16% Change
More quotes
Financials (USD)
Sales 2018 101 B
EBIT 2018 7 344 M
Net income 2018 3 826 M
Debt 2018 9 384 M
Yield 2018 -
Sales 2019 103 B
EBIT 2019 7 411 M
Net income 2019 4 119 M
Debt 2019 5 013 M
Yield 2019 -
P/E ratio 2018 12,42
P/E ratio 2019 10,92
EV / Sales2018 0,53x
EV / Sales2019 0,48x
Capitalization 44 505 M
More Financials
Company
Express Scripts Holding Co. engages in the provision of pharmacy benefit management services.Its services include network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, benefit-design consultation, drug utilization review, formulary management, and medical and... 
Sector
Drug Retailers
Calendar
07/31Earnings Release
More about the company
Surperformance© ratings of Express Scripts Holding Co
Trading Rating : Investor Rating :
More Ratings
Latest news on EXPRESS SCRIPTS HOLDING CO
06/22EXPRESS SCRIPTS : State auditor goes after pharmacy ‘middle men’
AQ
06/13MARKETS RIGHT NOW : Stocks slip after Fed raises rates
AQ
06/13Investors In Health Care Mergers Cheer Judge's OK Of AT&T-Time Warner Deal
AQ
06/07U.S. antitrust official says worries over limiting vertical deals 'misplaced'
RE
06/07CEO to be named soon for Berkshire, Amazon, JPMorgan healthcare venture
RE
06/07CEO to be named soon for Berkshire, Amazon, JPMorgan healthcare venture
RE
06/07EXPRESS SCRIPTS : to Provide Patients with Faster Path to Rare Disease Diagnosis..
AQ
06/07EXPRESS SCRIPTS' : Physician-Minded Solutions Deliver Greater Price Transparency..
PU
06/06EXPRESS SCRIPTS : invests firm that makes self-serve pharmacy kiosks
AQ
06/06PHARMACY EVERYWHERE : Express Scripts and MedAvail Announce Collaboration to Mak..
PU
More news
Sector news : Drug Retailers - NEC
06/21S&P Gains As Nasdaq Hits Record -- WSJ
DJ
06/20Walgreens on Pace for Highest Close Since April 2018 -- Data Talk
DJ
06/20GE Drops Out of the Dow After A Century -- WSJ
DJ
06/20DOW-NED BUT NOT OUT : Expulsion no body blow for GE shareholders
RE
06/20ANALYSIS - DOW-NED BUT NOT OUT : Expulsion no body blow for GE shareholders
RE
More sector news : Drug Retailers - NEC
4-Traders Strategies on EXPRESS SCRIPTS HOLDING CO 
EXPRESS SCRIPTS HOLDING - 2014
Testing the USD 68.3 support
BUY
EXPRESS SCRIPTS HOLDING - 2013
Trading opportunity
BUY
More Strategies
Latest Tweets
06/22Want the latest upgrades & downgrades for $KMPH $ESRX $CME $NBR $XTLY? Ch.. 
06/21Pharmalot.. Pharmalittle.. Good Morning.. a rash of shortages for a new shing.. 
06/19Express Scripts boots another online pharmacy — CareZone — from its network
1
06/19Express Scripts boots another online pharmacy — CareZone — from its network  
06/19Remember Pillpack? BREAKING: Express Scripts to boot another venture-backed ..
13
More tweets
Qtime:168
News from SeekingAlpha
06/18Will AT&T/Time Warner Ruling Accelerate M&A? 
06/13PREMARKET GAINERS AS OF 9 : 05 am (06/13/2018) 
06/13Headlines Don't Determine Stock Prices - Cramer's Mad Money (6/12/18) 
06/12After Hours Gainers / Losers (06/12/2018) 
06/12Mega-merger healthcare players up on positive court ruling for AT&T/Time Warn.. 
Chart EXPRESS SCRIPTS HOLDING CO
Duration : Period :
Express Scripts Holding Co Technical Analysis Chart | ESRX | US30219G1085 | 4-Traders
Technical analysis trends EXPRESS SCRIPTS HOLDING CO
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Average target price 85,1 $
Spread / Average Target 7,4%
EPS Revisions
Managers
NameTitle
Timothy C. Wentworth President, Chief Executive Officer & Director
George Paz Chairman
Neal Sample Chief Operating Officer & Executive Vice President
James M. Havel Chief Financial Officer & Executive Vice President
Steven B. Miller Chief Medical Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
EXPRESS SCRIPTS HOLDING CO7.32%44 505
CVS HEALTH CORPORATION-2.39%73 382
WALGREENS BOOTS ALLIANCE-6.90%67 047
MCKESSON CORPORATION-4.53%30 040
AMERISOURCEBERGEN1.83%20 552
CARDINAL HEALTH-11.90%16 771